{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:55:32Z","timestamp":1792684532910,"version":"4.5.0"},"reference-count":102,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C2087490"],"award-info":[{"award-number":["2019R1A2C2087490"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018M3A9H3024611"],"award-info":[{"award-number":["NRF-2018M3A9H3024611"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Genital herpes is a venereal disease caused by herpes simplex virus (HSV). Although HSV symptoms can be reduced with antiviral drugs, there is no cure. Moreover, because HSV infected individuals are often unaware of their infection, it is highly likely that they will transmit HSV to their sexual partner. Once infected, an individual has to live with HSV for their entire life, and HSV infection can lead to meningitis, encephalitis, and neonatal herpes as a result of vertical transmission. In addition, HSV infection increases the rates of human immunodeficiency virus (HIV) infection and transmission. Because of the high burden of genital herpes, HSV vaccines have been developed, but none have been very successful. In this review, we discuss the current status of genital herpes vaccine development.<\/jats:p>","DOI":"10.3390\/vaccines8030420","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T10:16:49Z","timestamp":1595931409000},"page":"420","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Vaccines against Genital Herpes: Where Are We?"],"prefix":"10.3390","volume":"8","author":[{"given":"Hyeon Cheol","family":"Kim","sequence":"first","affiliation":[{"name":"Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-1510","authenticated-orcid":false,"given":"Heung Kyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea"},{"name":"The Center for Epidemic Preparedness, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/424519","article-title":"Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract","volume":"190","author":"Gupta","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa035144","article-title":"Once-daily valacyclovir to reduce the risk of transmission of genital herpes","volume":"350","author":"Corey","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105376","DOI":"10.1155\/2009\/105376","article-title":"Once daily valacyclovir for reducing viral shedding in subjects newly diagnosed with genital herpes","volume":"2009","author":"Martens","year":"2009","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/QCO.0000000000000029","article-title":"Current thinking on genital herpes","volume":"27","author":"Hofstetter","year":"2014","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2471\/BLT.07.046128","article-title":"An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection","volume":"86","author":"Looker","year":"2008","journal-title":"Bull. World Health Organ."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.66.4.495","article-title":"Vidarabine therapy of neonatal herpes simplex virus infection","volume":"66","author":"Whitley","year":"1980","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.17.1.1-13.2004","article-title":"Neonatal herpes simplex infection","volume":"17","author":"Kimberlin","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/OLQ.0b013e3180f62bc7","article-title":"Neonatal herpes morbidity and mortality in California, 1995\u20132003","volume":"35","author":"Morris","year":"2008","journal-title":"Sex. Transm. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/sti.2008.033902","article-title":"Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992\u20132006","volume":"85","author":"Ryder","year":"2009","journal-title":"Sex. Transm. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0134","article-title":"Incidence of neonatal herpes simplex virus infections in the United States, 2006","volume":"127","author":"Flagg","year":"2011","journal-title":"Pediatrics"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJM198701293160503","article-title":"Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections","volume":"316","author":"Prober","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1136\/sti.2006.023549","article-title":"Proportion of new HIV infections attributable to herpes simplex 2 increases over time: Simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics","volume":"83","author":"Freeman","year":"2007","journal-title":"Sex. Transm. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/QAD.0000000000000646","article-title":"Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012","volume":"29","author":"Masese","year":"2015","journal-title":"AIDS"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","article-title":"The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008","volume":"40","author":"Chesson","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archinternmed.2009.177","article-title":"A pooled analysis of the effect of condoms in preventing HSV-2 acquisition","volume":"169","author":"Martin","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1258\/ijsa.2009.008477","article-title":"Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans","volume":"21","author":"Lingappa","year":"2010","journal-title":"Int. J. STD AIDS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.coviro.2011.12.001","article-title":"Viral and cellular contributions to herpes simplex virus entry into the cell","volume":"2","author":"Menotti","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrmicro1794","article-title":"Chromatin control of herpes simplex virus lytic and latent infection","volume":"6","author":"Knipe","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-micro-092611-150051","article-title":"Herpesvirus transport to the nervous system and back again","volume":"66","author":"Smith","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_21","first-page":"43","article-title":"Cutaneous herpes simplex virus lesions induced by ultraviolet radiation. A review of model systems and prophylactic therapy with oral acyclovir","volume":"85","author":"Spruance","year":"1988","journal-title":"Am. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bbi.2009.04.009","article-title":"Does psychosocial stress predict symptomatic herpes simplex virus recurrence? A meta-analytic investigation on prospective studies","volume":"23","author":"Chida","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00784-013-0986-3","article-title":"Herpes simplex virus reactivation and dental procedures","volume":"17","author":"Delvenne","year":"2013","journal-title":"Clin. Oral Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tim.2012.08.005","article-title":"A cultured affair: HSV latency and reactivation in neurons","volume":"20","author":"Wilson","year":"2012","journal-title":"Trends Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.immuni.2011.12.011","article-title":"Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense","volume":"36","author":"Kinnebrew","year":"2012","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Innate immune recognition: Mechanisms and pathways","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.1128\/JVI.00734-06","article-title":"PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0","volume":"80","author":"Everett","year":"2006","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/JVI.02308-07","article-title":"Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100","volume":"82","author":"Everett","year":"2008","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/JVI.00426-16","article-title":"SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1","volume":"90","author":"Brown","year":"2016","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1128\/JVI.03055-15","article-title":"Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response","volume":"90","author":"Conn","year":"2016","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12949","DOI":"10.1128\/JVI.02291-13","article-title":"SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication","volume":"87","author":"Kim","year":"2013","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.virol.2014.11.005","article-title":"Tetherin restricts HSV-2 release and is counteracted by multiple viral glycoproteins","volume":"475","author":"Liu","year":"2015","journal-title":"Virology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/emboj.2009.400","article-title":"A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses","volume":"29","author":"Lilley","year":"2010","journal-title":"EMBO J."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lilley, C.E., Chaurushiya, M.S., Boutell, C., Everett, R.D., and Weitzman, M.D. (2011). The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002084"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1099\/0022-1317-75-6-1223","article-title":"The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0","volume":"75","author":"Maul","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.celrep.2019.04.020","article-title":"Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication","volume":"28","author":"Zhang","year":"2019","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11541","DOI":"10.1128\/JVI.76.22.11541-11550.2002","article-title":"Alpha\/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1","volume":"76","author":"Sainz","year":"2002","journal-title":"J. Virol."},{"key":"ref_38","first-page":"151","article-title":"Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon","volume":"176","author":"Movshovitz","year":"1987","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1172\/JCI59259","article-title":"Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency","volume":"121","author":"Lorenzo","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/cid\/cir610","article-title":"Severe viral infections and primary immunodeficiencies","volume":"53","author":"Dropulic","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI111678","article-title":"Evolution of recurrent herpes simplex lesions. An immunohistologic study","volume":"75","author":"Cunningham","year":"1985","journal-title":"J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1172\/JCI1758","article-title":"Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes","volume":"101","author":"Koelle","year":"1998","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.immunol.25.022106.141634","article-title":"Mucosal dendritic cells","volume":"25","author":"Iwasaki","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.4049\/jimmunol.180.5.3122","article-title":"Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells","volume":"180","author":"Wong","year":"2008","journal-title":"J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4(+) T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"104755","DOI":"10.1016\/j.antiviral.2020.104755","article-title":"Multivalent DNA vaccine protects against genital herpes by T-cell immune induction in vaginal mucosa","volume":"177","author":"Kim","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1128\/JVI.00474-07","article-title":"Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells","volume":"81","author":"Hoshino","year":"2007","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1084\/jem.175.5.1337","article-title":"Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: Implications for the fate of virally infected neurons","volume":"175","author":"Simmons","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1084\/jem.20082039","article-title":"Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus","volume":"205","author":"Iijima","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2567.2004.02081.x","article-title":"Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina","volume":"114","author":"Sajic","year":"2005","journal-title":"Immunology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"18973","DOI":"10.1073\/pnas.1006614107","article-title":"Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes","volume":"107","author":"Schiffer","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.20061792","article-title":"Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation","volume":"204","author":"Zhu","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7ra16","DOI":"10.1126\/scitranslmed.3000193","article-title":"Frequent release of low amounts of herpes simplex virus from neurons: Results of a mathematical model","volume":"1","author":"Schiffer","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1074-7613(03)00112-2","article-title":"Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia","volume":"18","author":"Khanna","year":"2003","journal-title":"Immunity"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004300050043","article-title":"The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial","volume":"186","author":"Skinner","year":"1997","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0264-410X(98)00470-8","article-title":"Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10)","volume":"17","author":"Aurelian","year":"1999","journal-title":"Vaccine"},{"key":"ref_58","first-page":"235","article-title":"A double-blind study of the efficacy and safety of the ICP10deltaPK vaccine against recurrent genital HSV-2 infections","volume":"70","author":"Casanova","year":"2002","journal-title":"Cutis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/514103","article-title":"Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: Results of a placebo-controlled vaccine trial","volume":"176","author":"Straus","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials. Chiron HSV Vaccine Study Group","volume":"282","author":"Corey","year":"1999","journal-title":"JAMA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.330.6002.304","article-title":"Immunology. Painful failure of promising genital herpes vaccine","volume":"330","author":"Cohen","year":"2010","journal-title":"Science"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vaccine.2019.09.090","article-title":"A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2","volume":"38","author":"Bernstein","year":"2020","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fimmu.2019.00500","article-title":"An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine","volume":"10","author":"Agelidis","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.antiviral.2012.09.020","article-title":"Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection","volume":"96","author":"Antoine","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1128\/JVI.02659-05","article-title":"Diversity of the CD8 + T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes","volume":"80","author":"Hosken","year":"2006","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10875-010-9441-2","article-title":"Diversity in CD8 (+) T cell function and epitope breadth among persons with genital herpes","volume":"30","author":"Laing","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"12899","DOI":"10.1073\/pnas.2131705100","article-title":"Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor","volume":"100","author":"Koelle","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.4049\/jimmunol.166.6.4049","article-title":"CD8 CTL from genital herpes simplex lesions: Recognition of viral tegument and immediate early proteins and lysis of infected cutaneous cells","volume":"166","author":"Koelle","year":"2001","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1128\/JVI.72.9.7476-7483.1998","article-title":"Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions","volume":"72","author":"Koelle","year":"1998","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1743-422X-10-317","article-title":"Single dose of glycoprotein K (gK)-deleted HSV-1 live-attenuated virus protects mice against lethal vaginal challenge with HSV-1 and HSV-2 and induces lasting T cell memory immune responses","volume":"10","author":"Iyer","year":"2013","journal-title":"Virol. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1016\/j.vaccine.2018.03.075","article-title":"Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses","volume":"36","author":"Stanfield","year":"2018","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vaccine.2018.11.042","article-title":"The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes","volume":"37","author":"Bernstein","year":"2019","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/vim.2017.0033","article-title":"Optimized DNA Vaccine Enhanced by Adjuvant IL28B Induces Protective Immune Responses Against Herpes Simplex Virus Type 2 in Mice","volume":"30","author":"Zhou","year":"2017","journal-title":"Viral Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/1348-0421.12482","article-title":"Evaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice","volume":"61","author":"Liu","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1128\/JVI.75.3.1427-1436.2001","article-title":"Role of the UL25 gene product in packaging DNA into the herpes simplex virus capsid: Location of UL25 product in the capsid and demonstration that it binds DNA","volume":"75","author":"Ogasawara","year":"2001","journal-title":"J. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/jvi.61.5.1735-1737.1987","article-title":"Processing of the herpes simplex virus type 2 glycoprotein gG-2 results in secretion of a 34,000-Mr cleavage product","volume":"61","author":"Su","year":"1987","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/jvi.54.3.825-832.1985","article-title":"Synthesis and processing of glycoprotein gG of herpes simplex virus type 2","volume":"54","author":"Balachandran","year":"1985","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1099\/0022-1317-67-4-737","article-title":"Characterization of a herpes simplex virus type 2-specified glycoprotein with affinity for N-acetylgalactosamine-specific lectins and its identification as g92K or gG","volume":"67","author":"Olofsson","year":"1986","journal-title":"J. Gen. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Viejo-Borbolla, A., Martinez-Martin, N., Nel, H.J., Rueda, P., Martin, R., Blanco, S., Arenzana-Seisdedos, F., Thelen, M., Fallon, P.G., and Alcami, A. (2012). Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002497"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/ncomms7163","article-title":"Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization","volume":"6","author":"Martin","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Onnheim, K., Ekblad, M., Gorander, S., Bergstrom, T., and Liljeqvist, J.A. (2016). Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection. Viruses, 8.","DOI":"10.3390\/v8040110"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1128\/JVI.00849-11","article-title":"Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone","volume":"85","author":"Awasthi","year":"2011","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1128\/JVI.01130-14","article-title":"Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes","volume":"88","author":"Awasthi","year":"2014","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Awasthi, S., Hook, L.M., Shaw, C.E., Pahar, B., Stagray, J.A., Liu, D., Veazey, R.S., and Friedman, H.M. (2017). An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006141"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1080\/21645515.2017.1323604","article-title":"A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model","volume":"13","author":"Awasthi","year":"2017","journal-title":"Hum. Vaccin Immunother."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Egan, K., Hook, L.M., Naughton, A., Friedman, H.M., and Awasthi, S. (2020). Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection. Hum. Vaccin Immunother., 1\u20135.","DOI":"10.1080\/21645515.2020.1749509"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2018.11.076","article-title":"A trivalent gC2\/gD2\/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection","volume":"37","author":"Hook","year":"2019","journal-title":"Vaccine"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Awasthi, S., Hook, L.M., Pardi, N., Wang, F., Myles, A., Cancro, M.P., Cohen, G.H., Weissman, D., and Friedman, H.M. (2019). Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes. Sci. Immunol., 4.","DOI":"10.1126\/sciimmunol.aaw7083"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13365-014-0302-2","article-title":"Animal models of herpes simplex virus immunity and pathogenesis","volume":"21","author":"Kollias","year":"2015","journal-title":"J. Neurovirol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1128\/jvi.66.4.2157-2169.1992","article-title":"Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency","volume":"66","author":"Sawtell","year":"1992","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Hensel, M.T., Marshall, J.D., Dorwart, M.R., Heeke, D.S., Rao, E., Tummala, P., Yu, L., Cohen, G.H., Eisenberg, R.J., and Sloan, D.D. (2017). Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir. J. Virol., 91.","DOI":"10.1128\/JVI.02257-16"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-019-0129-1","article-title":"Successful application of prime and pull strategy for a therapeutic HSV vaccine","volume":"4","author":"Bernstein","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/146.3.397","article-title":"Genital herpes in guinea pigs: Pathogenesis of the primary infection and description of recurrent disease","volume":"146","author":"Stanberry","year":"1982","journal-title":"J. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000149647","article-title":"Recurrent genital herpes simplex virus infection in guinea pigs","volume":"24","author":"Stanberry","year":"1985","journal-title":"Intervirology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"14632","DOI":"10.1128\/JVI.79.23.14632-14639.2005","article-title":"The cotton rat provides a novel model to study genital herpes infection and to evaluate preventive strategies","volume":"79","author":"Yim","year":"2005","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Crostarosa, F., Aravantinou, M., Akpogheneta, O.J., Jasny, E., Shaw, A., Kenney, J., Piatak, M., Lifson, J.D., Teitelbaum, A., and Hu, L. (2009). A macaque model to study vaginal HSV-2\/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0008060"},{"key":"ref_99","first-page":"38","article-title":"Natural herpes simplex infection in the owl monkey (Aotus trivirgatus)","volume":"19","author":"Melendez","year":"1969","journal-title":"Lab. Anim. Care"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/eji.200323797","article-title":"Toll-like receptor expression in murine DC subsets: Lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines","volume":"33","author":"Edwards","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1016\/j.vaccine.2011.09.046","article-title":"Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons","volume":"29","author":"Wald","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:52:04Z","timestamp":1760176324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":102,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["vaccines8030420"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8030420","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]}}}